Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
983.77M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Employees
-
IPO
Jan 29, 2020
P/E
6.20
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
2.54
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
24.02%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
5.87%
SMA50
8.84%
SMA200
6.73%
Trades
Shs Outstand
62.50M
Shs Float
62.50M
52W High
15.80 -0.38%
52W Low
13.67 15.14%
Volatility
1.31% 1.55%
ATR (14)
0.22
RSI (14)
80.23
Beta
0.85
Rel Volume
0.81
Avg Volume
186.35K
Volume
150,516
Perf Week
2.67%
Perf Month
8.78%
Perf Quarter
10.22%
Perf Half Y
4.72%
Perf YTD
4.58%
Perf Year
10.53%
Perf 3Y
-2.78%
Perf 5Y
-46.19%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
15.66
Price
15.74
Change
0.51%
Jun-30-26 04:30PM
May-29-26 04:31PM
Apr-30-26 04:30PM
Mar-31-26 04:44PM
Feb-27-26 04:31PM
04:30PM Loading…
04:30PM
Jan-30-26 04:30PM
Dec-31-25 04:30PM
Nov-28-25 01:30PM
Nov-14-25 04:30PM
Nov-03-25 05:23PM
Oct-31-25 04:30PM
Oct-01-25 05:51PM
Sep-30-25 04:30PM
Sep-10-25 08:06PM
06:15PM Loading…
06:15PM
Sep-02-25 05:26PM
Aug-29-25 04:30PM
Jul-31-25 04:30PM
Jun-30-25 04:31PM
Jun-02-25 05:27PM
May-30-25 04:31PM
Apr-30-25 07:40PM
Apr-21-25 08:53PM
Apr-17-25 09:31PM
Apr-13-25 02:00PM
Mar-31-25 05:35PM
Mar-21-25 09:00AM
Mar-03-25 06:49PM
Feb-28-25 04:59PM
04:59PM Loading…
04:59PM
Feb-03-25 05:16PM
Jan-31-25 04:30PM
Jan-21-25 08:00AM
08:00AM
Jan-02-25 04:30PM
04:30PM
Dec-23-24 07:30PM
Dec-06-24 04:56PM
Nov-29-24 02:41PM
Nov-19-24 09:22PM
Nov-18-24 09:32PM
09:17PM
Oct-31-24 04:30PM
Oct-01-24 04:30PM
Sep-30-24 04:30PM
Sep-12-24 07:30PM
Sep-03-24 04:30PM
Aug-30-24 04:30PM
Aug-20-24 08:30PM
Aug-19-24 08:00PM
Aug-01-24 04:30PM
Jul-31-24 05:00PM
Jul-23-24 04:30PM
Jul-01-24 05:00PM
04:30PM
08:00AM
Jun-28-24 04:30PM
Jun-13-24 08:53AM
Jun-11-24 12:20PM
Jun-03-24 04:30PM
May-31-24 04:30PM
May-30-24 08:00AM
May-20-24 07:00AM
06:00AM
May-03-24 06:05PM
May-01-24 04:30PM
Apr-30-24 04:30PM
Mar-28-24 04:30PM
Nov-01-23 06:00PM
Oct-10-23 04:30PM
Sep-08-23 04:30PM
Aug-24-23 06:00PM
Jul-12-23 04:30PM
May-10-23 04:30PM
Apr-14-23 04:30PM
Mar-31-23 04:30PM
Feb-16-23 04:30PM
Jan-09-23 04:30PM
Oct-11-22 01:32PM
11:38AM
Aug-16-22 04:30PM
Jul-29-22 04:30PM
May-10-22 04:30PM
May-04-22 04:30PM
Apr-12-22 04:30PM
Feb-01-22 05:30PM
Jan-27-22 01:38PM
Jan-24-22 09:38AM
Nov-19-21 04:30PM
Nov-08-21 04:30PM
Apr-26-21 09:20AM
09:20AM
Nov-30-20 05:00PM
Mar-02-20 04:30PM
BlackRock Health Sciences Trust II's (BMEZ) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.
Portfolio ManagerDr. Xiang Liu Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fairbairn Robert WDirectorDec 18 '25Sale14.9810,294154,2040Dec 22 05:29 PM
Fairbairn Robert WDirectorDec 18 '25Sale14.9810,294154,2040Dec 22 05:29 PM
Fairbairn Robert WDirectorDec 19 '25Sale14.96060Dec 22 05:29 PM
Fairbairn Robert WDirectorDec 19 '25Sale14.96060Dec 22 05:29 PM